Dr. Alexandra I. Stavrakis, MD

Dr. Stavrakis practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Stavrakis' NPI, 1396097994, was assigned on October 5, 2012. Dr. Stavrakis holds California license A121667.

Dr. Stavrakis' primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Stavrakis' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Stavrakis is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Orthopaedic Surgery. Dmand AI also links Dr. Stavrakis to 2 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stavrakis practices, 4 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Stavrakis' primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Stavrakis is licensed in California.

CMS data shows 1,332 Medicare services from Dr. Stavrakis across 13 procedure codes in 2024, for 275 Medicare patients. Medicare paid $144,493 for them.

CMS counts 275 Medicare patients who saw Dr. Stavrakis in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have arthritis, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stavrakis' median patient age at 72, with 60% women.

In 2024, Dr. Stavrakis wrote 62 Medicare Part D claims for 42 patients. 100% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $82 in total drug cost. In 2023, CMS named 40 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Stavrakis for performance year 2024, reported as part of a group. Dr. Stavrakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stavrakis as offering telehealth. CMS counts 48 procedures of hip replacement by Dr. Stavrakis, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 47 papers to Dr. Stavrakis, published from 2010 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Arthroplasty, Replacement, Hip, Postoperative Complications and Arthroplasty, Replacement, Knee. Dr. Stavrakis has published most often in J Arthroplasty. Dr. Stavrakis' most frequent co-authors are Peter Paul Hsiue, MD, Amir Khoshbin, MD, FRCSC and Erik N. Zeegen, MD.

Dmand AI links Dr. Stavrakis to 1 clinical trial.

CMS Open Payments shows 241 general payments to Dr. Stavrakis from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Smith & Nephew, Inc. paid the most, $106,149.